This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dutta, S.
Right arrow Articles by Yoshida, S.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dutta, S.
Right arrow Articles by Yoshida, S.-I.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2005, p. 1660-1661, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1660-1661.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Alteration in the GyrA Subunit of DNA Gyrase and the ParC Subunit of Topoisomerase IV in Quinolone-Resistant Shigella dysenteriae Serotype 1 Clinical Isolates from Kolkata, India


arrow
LETTER
 
After the emergence of multidrug-resistant Shigella strains (8, 11), fluoroquinolones, such as ciprofloxacin and norfloxacin, were used in India to treat shigellosis. However, recently, genetically clonal ciprofloxacin-resistant Shigella dysenteriae serotype 1 strains have been isolated from sporadic and epidemic cases of dysentery in southern Asia, including eastern India (1, 9, 12; S. Dutta, A. Ghosh, K. Ghosh, D. Dutta, S. K. Bhattacharya, G. B. Nair, and S.-I. Yoshida, Letter, J. Clin. Microbiol. 41:5833-5834, 2003).

Quinolone resistance is linked mainly to mutations located in the quinolone resistance-determining regions (QRDRs) of DNA gyrase (GyrA and GyrB) and topoisomerase IV (ParC and ParE) (3, 4, 5). Replacement of residues Ser 80 and Glu 84 in parC commonly supplements gyrA mutations at residues Ser 83 and Asp 87 in members of the Enterobacteriaceae family to develop high fluoroquinolone resistance (13, 14). Besides topoisomerase mutations, overexpression of the energy-dependent multidrug efflux pump AcrAB due to mutations within repressor (AcrR) and multiple target and nontarget gene changes also contribute to fluoroquinolone resistance phenotypes in bacteria (2, 7, 15).

In this report, we demonstrate the mutations in the QRDRs of gyrA, gyrB, parC, and parE genes of fluoroquinolone-resistant S. dysenteriae serotype 1 strains isolated in Kolkata, India.

The type strain of S. dysenteriae serotype 1 (GTC 786) was procured from the culture collection of the Graduate School of Medicine, Gifu University, Gifu, Japan. Among 12 wild strains of S. dysenteriae serotype 1 included in this study, eight DS strains from sporadic cases (1) and one SKN outbreak strain (9) of dysentery showed resistance to fluoroquinolones, such as nalidixic acid, ciprofloxacin, and norfloxacin. The other three IBM strains were susceptible to all fluoroquinolones (8). These two groups of strains were compared to the type strain to determine any mutations.

The QRDRs of the gyrA (648-bp), gyrB (309-bp), parC (249-bp), and parE (290-bp) genes for all study strains were amplified with primer pairs designed from the genome sequence of S. flexneri 2457T, which is available at the DBGET database. For gyrA, the forward primer 5' TAC ACC GGT CAA CAT TGA GG 3' (nucleotide [nt] 24 to 43) and the reverse primer 5' TTA ATG ATT GCC GCC GTC GG 3' (nt 652 to 671) were used. For gyrB, the forward primer 5' TGA AAT GAC CCG CCG TAA AGG 3' (nt 1170 to 1190) and the reverse primer 5' GCT GTG ATA ACG CAG TTT GTC CGG G 3' (nt 1455 to 1479) were used. For parC, the forward primer 5' GTC TGA ACT GGG CCT GAA TGC 3' (nt 147 to 167) and the reverse primer 5' AGC AGC TCG GAA TAT TTC GAC AA 3' (nt 373 to 395) were used. For parE, the forward primer 5' ATG CGT GCG GCT AAA AAA GTG 3' (nt 1066 to 1086) and the reverse primer 5' TCG TCG CTG TCA GGA TCG ATA C 3' (nt 1334 to 1355) were used. The amplification was performed in a DNA thermal cycler as follows: (i) 30 cycles, with 1 cycle consisting of 1 min at 92°C, 1 min at 64°C, and 2 min at 74°C; and (ii) a final extension step of 10 min at 74°C. The purified PCR products were used directly as templates for sequencing, which was performed with CEQ dye terminator cycle sequencing using the Quickstart kit (Beckman Coulter, Inc.) in an automated sequencer (CEQ 2000 XL DNA analysis system; Beckman Coulter). The amino acid sequences of QRDRs were determined, and the homology of sequences was performed using the DNASIS program (Hitachi Software, Tokyo, Japan).

The MICs of nalidixic acid, ciprofloxacin, and norfloxacin were determined for each strain by using the Etest kit (AB Biodisk, Solna, Sweden), and the readings were interpreted using the National Committee for Clinical Laboratory Standards (NCCLS) breakpoint criteria (6).

In Table 1, two groups (groups A and B) were discerned on the basis of their fluoroquinolone resistance profiles. None of the strains possessed any mutation in the gyrB or parE gene. Mutations in amino acid sequences were detected in GyrA and ParC regions of all (100%) fluoroquinolone-resistant strains (group A). However, no single parC mutation was found without the concomitant presence of a gyrA mutation.


View this table:
[in this window]
[in a new window]
  		TABLE 1. MICs of antimicrobial agents and amino acid changes in the GyrA and ParC subunits of fluoroquinolone-resistant S. dysenteriae serotype 1

All fluoroquinolone-resistant strains showed two mutations, one mutation in gyrA at codon 83 (C->T transition), resulting in the replacement of serine (TCG) by leucine (TTG), and one mutation at codon 87 (G->A or A->G transition), resulting in the replacement of aspartic acid (GAC) by asparagine (AAC) or glycine (GGC). Another mutation at codon 80 (G->T transition) of parC resulted in the replacement of serine (AGC) by isoleucine (ATC), but no change was found at codon 84 (GAA; glutamic acid) of the gene. Since only the QRDRs of the genes were sequenced and the wild-type susceptibility was not knocked in, we do not rule out the possibility of mutations, although unlikely, present outside the region sequenced.

Our results corroborated earlier findings of mutations in the gyrA gene of quinolone-resistant S. dysenteriae serotype 1strains (10, 12). A difference in the amino acid substitution at codon 87 of the GyrA subunit of the sporadic strain (this study) and outbreak strain (12) is noteworthy. However, in addition to the gyrA mutation, the present study also reports another substitution at codon 80 of the parC gene of fluoroquinolone-resistant S. dysenteriae serotype 1 strains.


arrow
Nucleotide sequence accession numbers.
 
The partial sequences of gyrA, gyrB, parC, and parE genes containingQRDRs of fluoroquinolone-susceptible S. dysenteriae serotype 1 strain (IBM 1) reported in this article have been deposited in the GenBank database under accession no. AY648051, AY648052, AY648053, and AY648054, respectively.


arrow
ACKNOWLEDGMENTS
 
S. Dutta thanks the Japan Society for Promotion of Science for RONPAKU fellowship (DST-10114).


arrow
REFERENCES
 
    1
  1. Dutta, S., D. Dutta, P. Dutta, S. Matsushita, S. K. Bhattacharya, and S. I. Yoshida. 2003. Shigella dysenteriae serotype 1, Kolkata, India. Emerg. Infect. Dis. 9:1471-1474.[Medline]
    2. 2
  2. Ghosh, A. S., J. Ahamed, K. K. Chauhan, and M. Kundu. 1998. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae. Biochem. Biophys. Res. Commun. 242:54-56.[CrossRef][Medline]
    3. 3
  3. Heisig, P., H. Schedletzky, and H. Falkenstein-Paul. 1993. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:696-701.[Abstract/Free Full Text]
    4. 4
  4. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.[Abstract/Free Full Text]
    5. 5
  5. Maxwell, A. 1992. The molecular basis of quinolone action. J. Antimicrob. Chemother. 30:409-414.[Free Full Text]
    6. 6
  6. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed., vol. 20, no. 2. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    7. 7
  7. Oethinger, M., I. Podglajen, W. V. Kern, and S. B. Levy. 1998. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42:2089-2094.[Abstract/Free Full Text]
    8. 8
  8. Pal, S. C., P. G. Sengupta, D. Sen, S. K. Bhattacharya, and B. C. Deb. 1989. Epidemic shigellosis due to Shigella dysenteriae type 1 in South Asia. Ind. J. Med. Res. 89:57-64.[Medline]
    9. 9
  9. Pazhani, G. P., B. Sarkar, T. Ramamurthy, S. K. Bhattacharya, Y. Takeda, and S. K. Niyogi. 2004. Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India. Antimicrob. Agents Chemother. 48:681-684.[Abstract/Free Full Text]
    10. 10
  10. Rahaman, M., G. Mauff, J. Levy, M. Couturier, G. Pulverer, N. Glasdorff, and J. P. Butzler. 1994. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob. Agents Chemother. 38:2488-2491.[Abstract/Free Full Text]
    11. 11
  11. Sen, D., P. Dutta, B. C. Deb, and S. C. Pal. 1988. Nalidixic acid resistant Shigella dysenteriae type 1 in eastern India. Lancet 2:911.[Medline]
    12. 12
  12. Talukder, K. A., B. K. Khajanchi, M. A. Islum, D. K. Dutta, Z. Islam, A. Safe, G. Y. Khan, K. Alam, M. A. Hossain, S. Malla, S. K. Niyogi, M. Rahman, H. Watanabe, G. B. Nair, and D. A. Sack. 2004. Genetic relatedness of ciprofloxacin resistant Shigella dysenteriae type 1 isolated in south Asia. J. Antimicrob. Chemother. 54:730-734.[Abstract/Free Full Text]
    13. 13
  13. Vila, J., J. Ruiz, F. Marco, A. Barcelo, P. Goni, E. Giralt, and T. J. D. Anta. 1994. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38:2477-2479.[Abstract/Free Full Text]
    14. 14
  14. Vila, J., J. Ruiz, P. Goni, and T. J. D. Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.[Abstract/Free Full Text]
    15. 15
  15. Wang, H., J. L. Dzink-Fox, M. Chen, and S. B. Levy. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutation. Antimicrob. Agents Chemother. 45:1515-1521.[Abstract/Free Full Text]
Shanta Dutta*
Division of Microbiology, National Institute of Cholera and Enteric Diseases, P-33 CIT Rd., Scheme XM, P.O. Box 177, Beliaghata, Kolkata, India,1

Yoshiaki Kawamura
Takayuki Ezaki
Department of Microbiology, Regeneration and Advanced Medical  Science, Graduate School of Medicine, Gifu University, Gifu, Japan,2

Gopinath Balakrish Nair
International Center for Diarrhoeal Diseases and Research, Bangladesh, Dhaka, Bangladesh,3

Ken-Ichiro Iida
Shin-Ichi Yoshida
Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan,4

* Phone: 91-33-2350-0448, Fax: 91-33-2350-5066, E-mail: shanta1232001{at}yahoo.co.in

Antimicrobial Agents and Chemotherapy, April 2005, p. 1660-1661, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1660-1661.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pu, X.-Y., Pan, J.-C., Wang, H.-Q., Zhang, W., Huang, Z.-C., Gu, Y.-M. (2009). Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother 63: 917-920 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dutta, S.
Right arrow Articles by Yoshida, S.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dutta, S.
Right arrow Articles by Yoshida, S.-I.

Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»